RecruitingNot ApplicableNCT02290834
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
Sponsor
Massachusetts General Hospital
Enrollment
200 participants
Start Date
Mar 1, 2015
Study Type
INTERVENTIONAL
Conditions
Summary
This research study evaluates the effect of chemotherapy on cognition (thinking) and the brain in people with breast cancer.
Eligibility
Sex: FEMALEMin Age: 60 Years
Plain Language Summary
Simplified for easier understanding
This trial is studying how chemotherapy affects thinking, memory, and brain structure in older women with breast cancer, to better understand and manage what is sometimes called 'chemo brain.'
**You may be eligible if...**
- You are a woman aged 60 or older
- You have a new diagnosis of invasive breast cancer
- Your treatment plan includes chemotherapy
- Your life expectancy is at least 1 year
- Your general health score (Karnofsky) is 80 or above
- You are able to understand and complete questionnaires in English
**You may NOT be eligible if...**
- You have a prior history of cancer (other than certain skin or cervical cancers)
- You have a known neurological condition affecting memory or thinking
- You have significant hearing or vision loss that would affect testing
- You are already receiving cancer treatment
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERCognitive, functional and subjective assessments
Cognitive and functional assessments
DEVICEMRI
Magnetic Resonance Imaging (MRI) Scan
RADIATIONPET Scan
Positron Emission Tomography (PET) Scan
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02290834
Related Trials
Genomic Services Research Program
NCT025959571 location
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
NCT052833304 locations
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NCT070671381 location
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
NCT068852031 location
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
NCT06103864316 locations